A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
University of California, Davis
University of California, Davis
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Florida
Institut du Cancer de Montpellier - Val d'Aurelle
University of Nebraska
Guerbet
Mayo Clinic
Tanabe Pharma America, Inc.
Massive Bio, Inc.
BioXcel Therapeutics Inc
Jonsson Comprehensive Cancer Center
Jagiellonian University
National Cancer Institute (NCI)
University of Utah
Taproot Health
RECORDATI GROUP
Charite University, Berlin, Germany
British Columbia Cancer Agency
Stanford University
Merck Sharp & Dohme LLC